-
Joyina i-JYMed Peptide e-Pharmaconex 2025
I-JYMed Peptide iyajabula ukukumemela ku-Pharmaconex 2025, eyenzeka kusukela ngoSepthemba 1–3, 2025, e-Egypt International Exhibition Center (EIEC) eCairo. Ukumboza indawo yombukiso engamamitha-skwele ayi-12,000+, umcimbi uzosingatha ababukisi abangu-350+ futhi kulindeleke ukuthi uhehe 8,000+ ochwepheshe...Funda kabanzi -
Joyina i-JYMed Peptide e-CPhI Korea 2025
I-JYMed Peptide ijabule ukukumemela ku-CPhI Korea 2025, ezokwenzeka kusukela ngo-Agasti 26–28, 2025, e-COEX Convention & Exhibition Center e-Seoul. Njengoba uthatha amamitha-skwele ayi-15,000, umcimbi kulindeleke ukuthi usingathe ababukisi abangaphezu kuka-450 futhi wamukele izivakashi ezingochwepheshe ezingaphezu kwezi-10,000. Ngo-2024...Funda kabanzi -
Joyina i-JYMed e-CPHI South East Asia 2025
Siyajabula ukujoyina abaholi bezimboni e-CPHI South East Asia 2025, okwenzeka kusukela ngoJulayi 16 kuya ku-18 e-MITEC e-Kuala Lumpur. Umcimbi uhlanganisa ama-square metres angu-15,000 futhi uzohlanganisa abantu abangaba ngu-400. Bangaphezu kuka-8,000 ochwepheshe okulindeleke ukuba bathamele, kanye namasemina namaforamu angama-60+ ...Funda kabanzi -
I-CPHI Shanghai 2025
Kusukela mhla zingama-24 kuya kumhla zingama-26 kuNhlangulana wezi-2025, i-CPhI China yesi-23 ibanjelwe ngempumelelo e-Shanghai New International Expo Centre! Umongameli we-JYMed uMnu. Iqembu lizibandakanye ngqo ne-l...Funda kabanzi -
Hlangana ne-JYMed evikini le-Interphex e-Tokyo 2025
Siyajabula ukumemezela ukuthi i-JYMed izobe ikhonjiswa e-Interphex Week Tokyo kusukela ngoJulayi 9 kuya ku-11, 2025, e-Tokyo Big Sight (Ariake). Lo mcimbi omkhulu uhlanganisa ababukisi abangaphezu kuka-90 kanye nochwepheshe abangaba ngu-34,000 abavela kuzo zonke izimboni zemithi nezimonyo. Njengenye ye-Asia '...Funda kabanzi -
Joyina i-JYMed e-CPHI China 2025
I-CPHI China 2025 izokwenzeka kusukela ngoJuni 24–26, 2025, e-Shanghai New International Expo Center (SNIEC). Njengoba uthatha ngaphezu kwamamitha-skwele angu-230,000, umcimbi uzosingatha ababukisi abangaphezu kuka-3,500 futhi uhehe ochwepheshe bezimboni abangaphezu kuka-100,000. Njengenye yezindawo ezinkulu nezinamandla kakhulu e-Asia...Funda kabanzi -
ISISEKO SOKHIQIZWA KWE-PEPTIDE KA-JYMED E-HUBEI SIPHASE UKUHLOLWA KWE-FDA LESIBILI OKULANDELANA
I-Hubei JXBio Pharmaceutical Co., Ltd., indawo yokukhiqiza i-peptide ezinikele ye-JYMed, iqedele ngempumelelo okunye ukuhlola endaweni okwenziwa yi-US Food and Drug Administration (FDA) kusukela ngoMashi 10-14. Ukuhlolwa, okuyingxenye yokuhlolwa kwe-Drug Quality Assurance, kuhlaziye amasistimu abalulekile afaka ikhwalithi, umkhiqizo...Funda kabanzi -
U-JYMED PEPTIDE UTHOLA IZIQINISEKISO ZAMAQUALITY EZINTATHU
I-JYMed isebenzise uhlelo oluqinile lokuphatha ikhwalithi, ithola izitifiketi ezintathu zokuletha imikhiqizo namasevisi ngokungaguquki ahlangabezana namazinga omhlaba.Impumelelo yesitifiketi se-ISO 9001 ibonisa ukuthi inkampani inezinqubo ezichazwe kahle kanye namazinga okuphatha kwangaphakathi...Funda kabanzi -
HLANGANA NOJYMED EMICIMBINI ENGU-3 YEGLOBAL NGO-2025
Sijabule ngokujoyina i-ExpoFarma (Mexico City), IPhEB (St. Petersburg), kanye ne-In-Cosmetics Global (Amsterdam) ngo-2025. Woza uxhumane nethimba lethu futhi uhlole amathuba okusebenzisana. Izinsuku ze-Expo Farma 2025: Ephreli 2–4, 2025 Indawo: World Trade Center, Mexico City Isingathwe yi-Asociación...Funda kabanzi -
I-EUROPE PATENT INIKEZELWE I-LIRAGLUTIDE Synthesis
I-JYMed iklonyeliswe ngelungelo lobunikazi laseYurophu ngendlela yayo yokuqamba ye-Liraglutide. Lesi sigameko esiyingqopha-mlando sigqamisa ubuholi bethu obuqhubekayo ku-peptide R&D ne-IP. Le patent imele inqubo entsha yokuhlanganisa i-liraglutide, engagcini nje ngokuqinisekisa isivuno esizinzile kodwa futhi ngokuphawulekayo ...Funda kabanzi -
Izindaba Ezijabulisayo | I-JYMed Ivikela Ukufakwa Kwe-DMF Kwemikhiqizo Emisha Emihlanu e-US
Muva nje, i-Shenzhen JYMed Technology Co., Ltd. (ngemuva kwalokhu ebizwa ngokuthi “i-JYMed”) iqedele ngempumelelo ukufakwa kwefayela le-Drug Master File (DMF) kwemikhiqizo emihlanu eyengeziwe ne-US Food and Drug Administration (FDA), ngokuqhubekayo yandisa iphothifoliyo yomkhiqizo wayo. MAYELANA no-JYMED JYMed uyi...Funda kabanzi -
U-JYMED Ukumemela ku-PCHi 2025 e-Guangzhou
U-JYMED ukumema ngobuqotho ukuthi uhlanganyele nathi Embukisweni Wezithako Wezimonyo we-PCHi wango-2025 e-Guangzhou ukuze uhlole amathrendi emakethe yakamuva, ubuchwepheshe obusha, nemithetho yamazwe ngamazwe. Sivakashele e-Booth 6J07! I-Guan yango-2025...Funda kabanzi -
Izindaba Ezijabulisayo | Isikhungo Sokukhiqiza I-Peptide sika-JYMed Sithola Isitifiketi Se-WC
Muva nje, indawo yokukhiqiza i-peptide ye-JYMed, i-Hubei Jianxiang Biopharmaceutical Co., Ltd., ithole imibhalo emibili esemthethweni ekhishwe yi-Hubei Provincial Drug Administration: “Isaziso Somphumela Wokuhlolwa Wokuthobela Izidakamizwa GMP” (No. E GMP 2024-258 kanye No. E GMP 2024) a...26-26-26Funda kabanzi -
Izindaba Ezijabulisayo | Indawo Yokukhiqiza I-Semaglutide API Enkulu YaseChina Idlula Ukuhlolwa kwe-US FDA
Kusukela ngomhla ka-Agasti 26 kuya ku-Agasti 30, 2024, indawo yokukhiqiza i-peptide ye-JYMed, i-Hubei JX Bio-Pharmaceutical Co., Ltd., iphumelele ngempumelelo ukuhlolwa kwendawo okwenziwa yi-US Food and Drug Administration (FDA). Ukuhlola kuhlanganisa izindawo ezibalulekile ...Funda kabanzi -
2024 CPHI Milan Pharmaceutical Exhibition Recap
01. Uhlolojikelele Lombukiso Ngomhla ziyisi-8 kuMfumfu, uMbukiso Womhlaba Wonke Wezemithi we-CPHI wango-2024 waqala e-Milan. Njengomunye wemicimbi yaminyaka yonke ebaluleke kakhulu embonini yezemithi yomhlaba wonke, uhehe ababambiqhaza abavela emazweni nezifunda eziyi-166. Ngokudlula...Funda kabanzi -
Izindaba Ezijabulisayo | I-JYMed's Liraglutide API Ithola Isitifiketi Se-WC
Ngomhla ziyi-12 kuMfumfu, 2024, i-JYMed's Liraglutide API yathola isitifiketi Sokuqinisekisa Okubhaliwe (WC), okumaka isinyathelo esibalulekile sokuthunyelwa ngempumelelo kwe-API emakethe ye-EU. I-WC (Isiqiniseko Esibhaliwe)...Funda kabanzi -
Izindaba Ezijabulisayo: I-JYMed's Leuprorelin Acetate Idlula Ukuhlolwa Kokubhaliswa Kwezidakamizwa
Muva nje, i-JYMed Technology Co., Ltd. imemezele ukuthi i-Leuprorelin Acetate, ekhiqizwa inkampani engaphansi kwayo i-Hubei JX Bio-Pharmaceutical Co., Ltd., iphumelele ngempumelelo ukuhlolwa kokubhaliswa kwezidakamizwa. Imakethe Yezidakamizwa Yasekuqaleni...Funda kabanzi -
Sihalalisela I-Tirzepatide ye-JYMed Iqeda Ukugcwalisa kwe-US-DMF
I-JYMed Technology Co., Ltd. iyajabula ukumemezela ukuthi umkhiqizo wayo, i-Tirzepatide, iqede ngempumelelo ukubhaliswa kwe-Drug Master File (DMF) ne-US FDA (Inombolo ye-DMF: 040115) futhi yathola I-Acknowl ye-FDA...Funda kabanzi -
U-JYMed ufunda i-PCT 2024 e-Shanghai
I-PCT2024 Personal Care Technology Summit & Exhibition umcimbi onethonya elikhulu esifundeni sase-Asia-Pacific, ogxile ekushintshaneni kobuchwepheshe kanye nemibukiso embonini yemikhiqizo yokunakekelwa komuntu siqu.Inkundla izohlanganisa izici ezihlukahlukene zemboni yokunakekelwa komuntu siqu, kuhlanganise nezobuchwepheshe ku...Funda kabanzi -
I-JYMed Peptide ikumema ukuthi uhambele uMbukiso Wezithako Zezimonyo wase-Korea wango-2024
Indawo: Isikhungo Sombukiso Samazwe Ngamazwe sase-Korea Usuku: Julayi 24-26, 2024 Isikhathi: 10:00 AM - 5:00 PM Ikheli: I-COEX Exhibition Center Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 I-In-cosmetics iyiqembu elihamba phambili lemibukiso yomuntu siqu embukisweni wamazwe ngamazwe...Funda kabanzi
